Session 7A. Modelling the impact of policy changes on infectious diseases risks in prison
Tracks
Track 1
| Thursday, October 1, 2026 |
| 10:30 AM - 12:00 PM |
| Diamond 1 |
Speaker
Jason Andrews
Professor
Stanford University
Modelling systematic screening, case finding, and mass incarceration as a driver of tuberculosis
10:30 AM - 11:00 AMBiography
Jason Andrews is a Professor at Stanford University and a physician-scientist who studies infectious diseases, including tuberculosis. For the past thirteen years, he has led large-scale tuberculosis screening and prevention studies in prisons in Brazil, work that examines how the disease spreads in incarcerated populations.
Professor Peter Vickerman
Professor of Infectious Disease Modelling
University of Bristol
Modelling the impact of Russia's drug policy on HIV transmission on people who inject drugs
11:00 AM - 11:15 AMBiography
Jack Stone
Associate Professor
Bristol Medical School, University of Bristol
Modelling the contribution of incarceration to TB transmission in Ukraine
11:15 AM - 11:30 AMBiography
Farah Houdroge
Senior Research Officer
Burnet Institute
Health implications of a policy shift to long-acting opioid agonist therapies for opioid use disorder in Canadian federal prisons: a modelling study
11:30 AM - 11:45 AMBiography
Dr Farah Houdroge is a senior research officer at the Burnet Institute's Modelling and Biostatistics Group. She specialises in infectious disease modelling and health economic evaluation, with a focus on viral hepatitis elimination.
Dr. Matthew Akiyama
Associate Professor Of Medicine
Albert Einstein College Of Medicine
Modelling the cost-effectiveness of the MOSAIC study (mitigation of COVID-19 through onsite testing and education among formerly incarcerated individuals)
11:45 AM - 12:00 PMBiography
Eleanor is an infectious disease modeller and health economist based in Bristol, UK. Her expertise lies in modelling the cost-effectiveness of vaccination programmes and public health interventions. She has collaborated with researchers at the Albert Einstein College of Medicine in New York to evaluate the cost-effectiveness of the MOSAIC intervention.
Formalities
Q&A
12:00 PM - 12:00 PMBiography